Table 4.
Effects of type of dialyzer membranes on inflammation status.
| Reference | Treatment Duration (Months) | Type of Membrane | Inflammatory Marker Outcomes |
|---|---|---|---|
| Dębska-Ślizień et al., 2014 [80] |
6 | Polysulfone (low flux) | CRP: 9.3 ± 19.5 to 6.0 ± 6.9 mg/dL |
| Polysulfone (high flux) | CRP: 12.2 ± 27.8 to 6.5 ± 9.2 mg/dL | ||
| Movili et al., 2015 [81] |
12 | Usual hemodialysis | CRP: 5.1 ± 6.8 to 5.3 ± 5.0 mg/dL |
| Hemodiafiltration | CRP: 6.8 ± 7.0 to 2.3 ± 2.4 mg/dL | ||
| Zickler et al., 2017 [66] | 1 | Polyarylethersulfone/polyvinylpyrrolidone (medium cutoff) |
TNF-α: 24.1 ± 8.1 to 20.6 ± 5.8 pg/mL IL-6: 9.0 ± 13.2 to 6.0 ± 5.9 pg/mL CRP: 15.3 ± 30.0 to 9.3 ± 14.5 mg/dL |
| Polyarylethersulfone/polyvinylpyrrolidone (high flux) |
TNF-α: 23.4 ± 7.3 to 22.0 ± 6.0 pg/mL IL-6: 9.8 ± 20.5 to 5.5 ± 4.5 pg/mL CRP: 13.4 ± 25.5 to 9.6 ± 15.7 mg/dL |
||
| Galli et al., 2005 [82] |
6 | Polymethylmethacrylate (high flux) |
TNF-α: 18.7 ± 4.3 to 15.1 ± 3.1 a pg/mL IL-6: 5.0 ± 1.9 to 3.1 ± 0.6 a pg/mL CRP: 22.7 ± 33.9 to 12.1 ± 9.1 mg/dL |
| Cellulose acetate/cuprammonium rayon (low flux) |
TNF-α: 19.0 ± 4.0 to 21.5 ± 5.5 pg/mL IL-6: 5.3 ± 2.1 to 5.8 ± 2.3 pg/mL CRP: 25.8 ± 28.6 to 27.4 ± 24.0 mg/dL |
Abbreviations: CRP, C-reactive protein; IL-6, interleukin-6; TNF-α, tumor necrosis factor alpha; a significantly different (p < 0.05) compared to pre-treatment.